Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Corcept Therapeutics (CORT) over the last 12 years, with Dec 2024 value amounting to $141.2 million.

  • Corcept Therapeutics' Consolidated Net Income fell 58.34% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.2 million, marking a year-over-year decrease of 25.15%. This contributed to the annual value of $141.2 million for FY2024, which is 33.04% up from last year.
  • As of FY2024, Corcept Therapeutics' Consolidated Net Income stood at $141.2 million, which was up 33.04% from $106.1 million recorded in FY2023.
  • Corcept Therapeutics' 5-year Consolidated Net Income high stood at $141.2 million for FY2024, and its period low was $101.4 million during FY2022.
  • In the last 3 years, Corcept Therapeutics' Consolidated Net Income had a median value of $106.1 million in 2023 and averaged $116.3 million.
  • Per our database at Business Quant, Corcept Therapeutics' Consolidated Net Income declined by 9.86% in 2022 and then skyrocketed by 33.04% in 2024.
  • Yearly analysis of 5 years shows Corcept Therapeutics' Consolidated Net Income stood at $106.0 million in 2020, then increased by 6.13% to $112.5 million in 2021, then declined by 9.86% to $101.4 million in 2022, then grew by 4.66% to $106.1 million in 2023, then spiked by 33.04% to $141.2 million in 2024.